Suchergebnisse - "Cubillo, Antonio"

PubPharm (7)

1

Efficacy and safety of dilpacimab (ABT-165) versus bevacizumab plus FOLFIRI in metastatic colorectal cancer : a phase II study

enthalten in: Future oncology (London, England) | 2022

von Strickler, J. | Cubillo, A. | Liang, J. | +7

2

Toxicity and antitumor activity of novel agents in elderly patients with cancer included in phase 1 studies

enthalten in: Investigational new drugs | 2021

von Ao, G. | de Miguel, M. | Gomes, A. | +7

3

Complete pathological response to neoadjuvant treatment is associated with better survival outcomes in patients with soft tissue sarcoma : Results of a retrospective multicenter study

enthalten in: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | 2021

von Bonvalot, S. | Wunder, J. | Gronchi, A. | +12

CommentIn: Eur J Surg Oncol. 2021 Aug;47(8):2207. - PMID 33895024

4

Doxorubicin-loaded nanoparticles for patients with advanced hepatocellular carcinoma after sorafenib treatment failure (RELIVE) : a phase 3 randomised controlled trial

enthalten in: The lancet. Gastroenterology & hepatology | 2019

von Merle, P. | Blanc, J. | Phelip, J. | +91

CommentIn: Lancet Gastroenterol Hepatol. 2019 Jun;4(6):418-420. - PMID 30954566

5

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours

enthalten in: Neuroendocrinology | 2018

von Raymond, E. | Kulke, M. | Qin, S. | +27

6

Phase I clinical and pharmacokinetic study of PM01183 (a tetrahydroisoquinoline, Lurbinectedin) in combination with gemcitabine in patients with advanced solid tumors

enthalten in: Investigational new drugs | 2017

von Paz-Ares, L. | Forster, M. | Boni, V. | +9

7

Resected duodenal gastrointestinal stromal tumour with an affected margin and exon 9 mutation : adjuvant therapy

enthalten in: Anti-cancer drugs | 2012

von Salas, N. | Cubillo, A.

1
[1]